Xanax (alprazolam) is not approved as a treatment for depression. It is FDA-approved for two conditions: generalized anxiety disorder and panic disorder. However, the relationship between Xanax and depression is more complicated than a simple no, because anxiety and depression frequently overlap, and the drug does appear to have some short-term effects on depressive symptoms.
What Xanax Is Actually Approved For
The FDA label for Xanax lists two approved uses: managing anxiety disorder and treating panic disorder, with or without agoraphobia. There is one line on the label that touches on mood: “Anxiety associated with depression is responsive to XANAX.” That narrow statement means if you have depression and anxiety comes along with it, Xanax may help with the anxiety piece. It does not mean Xanax treats the depression itself.
Xanax is classified as a Schedule IV controlled substance, meaning it carries a recognized potential for misuse and dependence. It belongs to the benzodiazepine class of drugs, which work by boosting the activity of a calming brain chemical called GABA. This is fundamentally different from how antidepressants work. Standard antidepressants (like SSRIs) gradually adjust serotonin signaling over weeks. Xanax amplifies GABA’s inhibitory effects within minutes, which is why it relieves anxiety quickly but doesn’t address the underlying neurochemistry of depression.
Does It Help With Depressive Symptoms?
A Cochrane review, considered one of the most rigorous forms of medical evidence, looked at whether alprazolam works for major depression. The conclusion: alprazolam may be moderately more effective than a placebo and roughly as effective as conventional antidepressants in reducing depressive symptoms. That sounds promising until you read the critical caveat. The reviewers could not determine whether the improvement came from a genuine antidepressant effect or simply from better sleep and less anxiety, both of which naturally lift mood scores on depression questionnaires.
This distinction matters. If Xanax makes you sleep better and feel less anxious, you’ll score lower on a depression rating scale without the drug actually treating your depression. That’s why major psychiatric guidelines, including those from both the American Psychiatric Association and the UK’s National Institute for Health and Care Excellence, explicitly state that benzodiazepines do not have an antidepressant effect. The APA does not recommend benzodiazepines as primary treatment even for people with depression who also have significant anxiety.
Why Doctors Sometimes Prescribe It Alongside Antidepressants
Where Xanax does show up in depression treatment is as a short-term add-on during the first few weeks of antidepressant therapy. Most antidepressants take two to six weeks to reach full effect, and during that gap, anxiety and insomnia can be intense. A prescriber might add a benzodiazepine briefly to bridge that window. The combination of an antidepressant plus a benzodiazepine can reduce early dropout from treatment, since patients feel some relief right away instead of waiting weeks with no improvement.
The catch is getting off the benzodiazepine once the antidepressant kicks in. Stopping a benzodiazepine after even a few weeks of regular use can cause rebound anxiety, insomnia, and a worsening of the very symptoms it was meant to control. This makes the bridge strategy useful in theory but risky in practice if the taper isn’t managed carefully.
Risks of Using Xanax for Mood Problems
The short-term relief Xanax provides can create a cycle that makes depression harder to treat over time. Physical dependence develops in roughly one third of people who take a benzodiazepine regularly for four weeks or longer. Alprazolam specifically carries the highest misuse liability among benzodiazepines because of its fast onset and the way it triggers dopamine release in the brain’s reward system, similar to stimulants. Its effects also wear off quickly, often requiring three to four doses per day, and the gaps between doses can produce rebound anxiety that feels worse than the original symptoms.
Long-term benzodiazepine use, defined in research as two months or more, introduces additional concerns. A large retrospective study of over 100,000 patients found that the risk of death was doubled in those prescribed benzodiazepines compared to controls. Aggressive behavior and heightened anger affect between 1% and 20% of users. And because Xanax is a central nervous system depressant, it can blunt motivation, slow thinking, and deepen the emotional flatness that many people with depression already struggle with.
One particularly alarming finding: disrupting sleep patterns by starting and then stopping alprazolam within just two weeks has been linked to increased suicide risk. For someone already dealing with depression, this makes unsupervised or erratic use especially dangerous.
What Withdrawal Looks Like
Stopping Xanax after regular use produces a withdrawal syndrome that can mimic or worsen depression. The most common pattern is rebound anxiety and insomnia appearing within one to four days of the last dose. A more severe withdrawal syndrome, lasting 10 to 14 days, can include irritability, difficulty concentrating, panic attacks, tremor, sweating, nausea, muscle pain, and palpitations. In some people, a third pattern emerges where anxiety symptoms return and persist until another form of treatment is started.
Withdrawal is more intense with short-acting benzodiazepines like alprazolam than with longer-acting ones. Abruptly stopping high doses can be life-threatening. About 40% of people who have used benzodiazepines for six months or longer experience withdrawal symptoms when a long-acting benzodiazepine is stopped suddenly, and the rate with fast-acting alprazolam is expected to be at least as high. The APA’s most recent relevant guideline, published in 2025, focuses specifically on how to taper benzodiazepines when the risks outweigh the benefits, reflecting growing clinical concern about how difficult these drugs are to stop.
What Works Better for Depression
First-line treatments for depression target the condition directly rather than masking its symptoms. SSRIs and similar antidepressants adjust serotonin and norepinephrine signaling over time, producing sustained improvement in mood, energy, and motivation. They take longer to work, but they don’t carry the dependence risk of benzodiazepines, and their benefits persist as long as you take them.
For people with both depression and significant anxiety, the overlap actually works in favor of standard antidepressants, since SSRIs are also first-line treatments for most anxiety disorders. A single medication can address both conditions without the added risks of a benzodiazepine. Cognitive behavioral therapy, either alone or combined with medication, also has strong evidence for treating depression with or without co-occurring anxiety.
If you’re currently taking Xanax and wondering whether it’s helping your mood, the key question is whether it’s addressing the root of your depression or simply smoothing over the anxiety and insomnia that come with it. Those are very different things, and the distinction shapes what treatment will actually help long term.